On the one hand, it can enhance anti-tumor immunity by cell death-triggered release of neoantigens, damage-associated molecular patterns (DAMPs, e.g. HMGB1, ATP, Hsp70) and proinflammatory substances (e.g. CXCL10 and CXCL16). Here, HSPA1A is linked to neoplasm.